A google alert led me to this local news article on the site of a local ABC affiliate in San Antonio, TX. It's compelling because it contains an interview with a physician using cabo on patients. He seems to be excited about what he's seeing in Prostate cancer patients using Cabo.There's a lot of garbage that gets published by financial analysts about EXEL and Cabo. This article just seems different because -- unlike a lot of what's written about Cabo and EXEL -- it looks like legit journalism rather than just blog-fodder to pump or trash EXEL's share price.http://www.ksat.com/news/Promising-prostate-cancer-drug/-/47...Would love to hear thoughts from anybody who follow EXEL more closely than I do...
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat